CLEAR-CMV: Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients (clinicaltrials.gov) - Nov 20, 2025 - P4 | N=40 | Not yet recruiting | Sponsor: University Health Network, Toronto
New P4 trial • Cytomegalovirus Infection • Infectious Disease • Respiratory Diseases • Transplantation
|